SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-298319
Filing Date
2014-08-06
Accepted
2014-08-06 16:34:20
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d744974d10q.htm 10-Q 595465
2 EX-31.1 d744974dex311.htm EX-31.1 8097
3 EX-31.2 d744974dex312.htm EX-31.2 8137
4 EX-32.1 d744974dex321.htm EX-32.1 4662
  Complete submission text file 0001193125-14-298319.txt   4250713

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arna-20140630.xml EX-101.INS 553879
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20140630.xsd EX-101.SCH 46436
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20140630_cal.xml EX-101.CAL 53715
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20140630_def.xml EX-101.DEF 254715
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20140630_lab.xml EX-101.LAB 360034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20140630_pre.xml EX-101.PRE 300568
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 141020452
SIC: 2834 Pharmaceutical Preparations